Biotech · Private company · Mountain View, CA, US
Osel, Inc.
Track this companyFree. Adds Osel, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials52 recruiting or active
Pipeline programs9From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline9
- Biospecimen CollectionPhase 1 · Advanced Clear Cell Renal Cell CarcinomaClinicalTrials.gov · fetched Nov 12, 2026
- Bone ScanPhase 1 · Advanced Clear Cell Renal Cell CarcinomaClinicalTrials.gov · fetched Nov 12, 2026
- CBM588 CapsulesPhase 1 · Advanced Clear Cell Renal Cell CarcinomaClinicalTrials.gov · fetched Nov 12, 2026
- Computed TomographyPhase 1 · Advanced Clear Cell Renal Cell CarcinomaClinicalTrials.gov · fetched Nov 12, 2026
- High dose LACTIN-V applicatorPhase 1 · Bacterial VaginosisClinicalTrials.gov · fetched Nov 12, 2026
- IpilimumabPhase 1 · Advanced Clear Cell Renal Cell CarcinomaClinicalTrials.gov · fetched Nov 12, 2026
- Low dose LACTIN-V applicatorPhase 1 · Bacterial VaginosisClinicalTrials.gov · fetched Nov 12, 2026
- Magnetic Resonance ImagingPhase 1 · Advanced Clear Cell Renal Cell CarcinomaClinicalTrials.gov · fetched Nov 12, 2026
- Medium dose LACTIN-V applicatorPhase 1 · Bacterial VaginosisClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials5
- Phase II Trial of Pembrolizumab/Chemotherapy With Live Biotherapeutic Product MO-03 in Patients With Early Stage Triple Negative Breast CancerPHASE2 · NOT_YET_RECRUITING · started Sep 1, 2026ClinicalTrials.gov NCT07552181 · fetched Nov 12, 2026
- Safety Study of MucoCept-CVNPHASE1 · RECRUITING · started Oct 6, 2025ClinicalTrials.gov NCT07181486 · fetched Nov 12, 2026
- CBM588 Capsules in Combination With Nivolumab and Ipilimumab for the Treatment of Advanced Stage Kidney CancerPHASE1 · UNKNOWN · started Jun 19, 2024ClinicalTrials.gov NCT06399419 · fetched Nov 12, 2026
- Safety Study of Lactobacillus Administered Vaginally to Healthy WomenPHASE1 · COMPLETED · started Nov 1, 2007ClinicalTrials.gov NCT00537576 · fetched Nov 12, 2026
- Intravaginal LACTIN-V for Prevention of Recurrent Urinary Tract InfectionPHASE2 · COMPLETED · started Mar 1, 2006ClinicalTrials.gov NCT00305227 · fetched Nov 12, 2026
NIH awards1
- Novel Antimicrobial Approach to Treat Chemoradiation Resistant Cervical Cancer by Selectively Inhibiting Lactobacillus inersFiscal year 2025 · $295.9KNIH RePORTER 1R43CA297979-01 · fetched Nov 12, 2026